Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was formed to produce improved, more potent shots that are simpler to manufacture.

The East Bank Development Authority is highlighting where the development stands in the first quarter of 2026.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Web hosts and website builders make building a website sound super easy: sign up, pick a ...

Allie is a financial writer and editor with over five years of experience. An investment banker turned journalist, she has previously reported on cryptocurrency for MT Newswires and edited ...